Fred discovered the science behind our advanced genotyping approach and leads product development. He founded TL Biolabs after being named one of the top 100 practicing scientists in the UK by The Times and became a Thiel Fellow in 2017.
Sam leads the commercial and operational elements of the business. Prior to TL Biolabs he helped triple the size of an IT services business and started a network for entrepreneurs. He was named to the Forbes 30 Under 30 2017 list for Science.
Brad completed his PhD at Berkeley and his post-doc at Harvard. Subsequently, he managed multimillion-dollar grants at the Bill & Melinda Gates foundation and developed a $30M advanced robotics program at the US Department of Energy.
George Church is a professor at Harvard and MIT and co-author of 453 papers, 105 patent publications, and Regenesis. He developed methods used for the first genome sequence, million-fold cost reductions since, DNA barcoding, DNA assembly from chips, and genome editing, writing and recoding. He co-initiated the BRAIN Initiative and Genome Projects to provide and interpret the world’s only open-access personal precision medicine datasets.
Marc Unger invented Multilayer Soft Lithography - the foundational technology of Fluidigm Corporation, where he drove the development of the core technology, manufacturing, and product lines. During his tenure, the company went public and achieved product revenues greater than $100M per year. He co-founded Hyalos Therapeutics in early 2017.